248 related articles for article (PubMed ID: 31450894)
1. IL-6 Impairs the Activity of Vitamin D3 in the Regulation of Epithelial-Mesenchymal Transition in Triple Negative Breast Cancer.
Abdel-Mohsen MA; Abo Deif SM; Abou-Shamaa LA
Asian Pac J Cancer Prev; 2019 Aug; 20(8):2267-2273. PubMed ID: 31450894
[TBL] [Abstract][Full Text] [Related]
2. Antrodia camphorata inhibits epithelial-to-mesenchymal transition by targeting multiple pathways in triple-negative breast cancers.
Hseu YC; Chang GR; Pan JY; Rajendran P; Mathew DC; Li ML; Liao JW; Chen WT; Yang HL
J Cell Physiol; 2019 Apr; 234(4):4125-4139. PubMed ID: 30146779
[TBL] [Abstract][Full Text] [Related]
3. Modeling vitamin D actions in triple negative/basal-like breast cancer.
LaPorta E; Welsh J
J Steroid Biochem Mol Biol; 2014 Oct; 144 Pt A():65-73. PubMed ID: 24239860
[TBL] [Abstract][Full Text] [Related]
4. MiR-508-3p inhibits cell invasion and epithelial-mesenchymal transition by targeting ZEB1 in triple-negative breast cancer.
Guo SJ; Zeng HX; Huang P; Wang S; Xie CH; Li SJ
Eur Rev Med Pharmacol Sci; 2018 Oct; 22(19):6379-6385. PubMed ID: 30338806
[TBL] [Abstract][Full Text] [Related]
5. 1Alpha,25-dihydroxyvitamin D3 induces de novo E-cadherin expression in triple-negative breast cancer cells by CDH1-promoter demethylation.
Lopes N; Carvalho J; Durães C; Sousa B; Gomes M; Costa JL; Oliveira C; Paredes J; Schmitt F
Anticancer Res; 2012 Jan; 32(1):249-57. PubMed ID: 22213313
[TBL] [Abstract][Full Text] [Related]
6. Down-regulation of vitamin D receptor in mammospheres: implications for vitamin D resistance in breast cancer and potential for combination therapy.
Pervin S; Hewison M; Braga M; Tran L; Chun R; Karam A; Chaudhuri G; Norris K; Singh R
PLoS One; 2013; 8(1):e53287. PubMed ID: 23341935
[TBL] [Abstract][Full Text] [Related]
7. GSK3β regulates epithelial-mesenchymal transition and cancer stem cell properties in triple-negative breast cancer.
Vijay GV; Zhao N; Den Hollander P; Toneff MJ; Joseph R; Pietila M; Taube JH; Sarkar TR; Ramirez-Pena E; Werden SJ; Shariati M; Gao R; Sobieski M; Stephan CC; Sphyris N; Miura N; Davies P; Chang JT; Soundararajan R; Rosen JM; Mani SA
Breast Cancer Res; 2019 Mar; 21(1):37. PubMed ID: 30845991
[TBL] [Abstract][Full Text] [Related]
8. Vitamin D regulation of HAS2, hyaluronan synthesis and metabolism in triple negative breast cancer cells.
Narvaez CJ; Grebenc D; Balinth S; Welsh JE
J Steroid Biochem Mol Biol; 2020 Jul; 201():105688. PubMed ID: 32360595
[TBL] [Abstract][Full Text] [Related]
9. Elevated TGF-β1 and -β2 expression accelerates the epithelial to mesenchymal transition in triple-negative breast cancer cells.
Kim S; Lee J; Jeon M; Nam SJ; Lee JE
Cytokine; 2015 Sep; 75(1):151-8. PubMed ID: 26088755
[TBL] [Abstract][Full Text] [Related]
10. MAGE-A is frequently expressed in triple negative breast cancer and associated with epithelial-mesenchymal transition.
Wang H; Sang M; Geng C; Liu F; Gu L; Shan B
Neoplasma; 2016; 63(1):44-56. PubMed ID: 26639233
[TBL] [Abstract][Full Text] [Related]
11. Mammary adipocytes bioactivate 25-hydroxyvitamin D₃ and signal via vitamin D₃ receptor, modulating mammary epithelial cell growth.
Ching S; Kashinkunti S; Niehaus MD; Zinser GM
J Cell Biochem; 2011 Nov; 112(11):3393-405. PubMed ID: 21769914
[TBL] [Abstract][Full Text] [Related]
12. SIRT1 enzymatically potentiates 1,25-dihydroxyvitamin D
Sabir MS; Khan Z; Hu C; Galligan MA; Dussik CM; Mallick S; Stone AD; Batie SF; Jacobs ET; Whitfield GK; Haussler MR; Heck MC; Jurutka PW
J Steroid Biochem Mol Biol; 2017 Sep; 172():117-129. PubMed ID: 28636886
[TBL] [Abstract][Full Text] [Related]
13. Phytoestrogen regulation of a Vitamin D3 receptor promoter and 1,25-dihydroxyvitamin D3 actions in human breast cancer cells.
Wietzke JA; Welsh J
J Steroid Biochem Mol Biol; 2003 Feb; 84(2-3):149-57. PubMed ID: 12710998
[TBL] [Abstract][Full Text] [Related]
14. Vitamin D and androgen receptor-targeted therapy for triple-negative breast cancer.
Thakkar A; Wang B; Picon-Ruiz M; Buchwald P; Ince TA
Breast Cancer Res Treat; 2016 May; 157(1):77-90. PubMed ID: 27120467
[TBL] [Abstract][Full Text] [Related]
15. Vitamin D modulates E-cadherin turnover by regulating TGF-β and Wnt signalings during EMT-mediated myofibroblast differentiation in A459 cells.
Sari E; Oztay F; Tasci AE
J Steroid Biochem Mol Biol; 2020 Sep; 202():105723. PubMed ID: 32603782
[TBL] [Abstract][Full Text] [Related]
16. Dihydrotanshinone-I modulates Epithelial Mesenchymal Transition (EMT) Thereby Impairing Migration and Clonogenicity of Triple Negative Breast Cancer Cells.
Kashyap A; Umar SM; Dev J R A; Prasad CP
Asian Pac J Cancer Prev; 2021 Jul; 22(7):2177-2184. PubMed ID: 34319041
[TBL] [Abstract][Full Text] [Related]
17. Antrodia salmonea suppresses invasion and metastasis in triple-negative breast cancer cells by reversing EMT through the NF-κB and Wnt/β-catenin signaling pathway.
Hseu YC; Lin YC; Rajendran P; Thigarajan V; Mathew DC; Lin KY; Way TD; Liao JW; Yang HL
Food Chem Toxicol; 2019 Feb; 124():219-230. PubMed ID: 30529123
[TBL] [Abstract][Full Text] [Related]
18. 1,25-Dihydroxyvitamin D3 Prevents Epithelial-Mesenchymal Transition of HMrSV5 Human Peritoneal Mesothelial Cells by Inhibiting Histone Deacetylase 3 (HDAC3) and Increasing Vitamin D Receptor (VDR) Expression Through the Wnt/β-Catenin Signaling Pathway.
Liu KH; Fu J; Zhou N; Yin W; Yang YY; Ouyang SX; Liang YM
Med Sci Monit; 2019 Aug; 25():5892-5902. PubMed ID: 31391414
[TBL] [Abstract][Full Text] [Related]
19. MART-10, a less calcemic vitamin D analog, is more potent than 1α,25-dihydroxyvitamin D3 in inhibiting the metastatic potential of MCF-7 breast cancer cells in vitro.
Chiang KC; Chen SC; Yeh CN; Pang JH; Shen SC; Hsu JT; Liu YY; Chen LW; Kuo SF; Takano M; Kittaka A; Sun CC; Juang HH; Chen TC
J Steroid Biochem Mol Biol; 2014 Jan; 139():54-60. PubMed ID: 24125734
[TBL] [Abstract][Full Text] [Related]
20. Chrysin inhibits metastatic potential of human triple-negative breast cancer cells by modulating matrix metalloproteinase-10, epithelial to mesenchymal transition, and PI3K/Akt signaling pathway.
Yang B; Huang J; Xiang T; Yin X; Luo X; Huang J; Luo F; Li H; Li H; Ren G
J Appl Toxicol; 2014 Jan; 34(1):105-12. PubMed ID: 24122885
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]